Lupin gets USFDA nod to market skin ointment The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.
Feedback
LUPIN 
Reputation: 2,149 • Dec 21, 2019 12:18 AM
Vote
Comment
Share